Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

In a recent study published in the journal Nature Medicine, researchers assessed the coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) against symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs) by genetic mismatch/distance (GD) analysis.

20 Jun 2022

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

In a recent study posted to the bioRxiv* preprint server, researchers at Weill Cornell Medical College assessed the cleavability of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and related coronaviruses by several proteases of the host.

19 Jun 2022

How effective are mRNA COVID-19 vaccine boosters against Omicron?

In a recent study posted to the medRxiv* preprint server, researchers University of Washington, University of Michigan, Duke University, and Veterans Affairs Portland Healthcare System assessed the effectiveness of the coronavirus disease 2019 (COVID-19) booster vaccines.

19 Jun 2022

Long-COVID risk reduced with Omicron versus Delta

In a recent study published in The Lancet, researchers at King's College London and ZOE Limited assessed the risk of long coronavirus disease (COVID) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants in the United Kingdom (UK).

19 Jun 2022

Combating monkeypox during COVID-19

Scientists describe the global prevalence and significance of the current monkeypox virus outbreak.

19 Jun 2022

Disease ecologist receives $3.5 million to take modeling to the next level with EpiMoRPH

Mathematical modeling - which combines math, statistics, computing and data - is a critical tool for public health professionals, who use it to study how diseases spread, predict the future course of outbreaks and evaluate strategies for controlling epidemics.

18 Jun 2022

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

When a person sneezes or coughs, they can potentially transmit droplets carrying viruses like SARS-CoV-2 to others in their vicinity.

17 Jun 2022

Nanoparticles may be the next-generation solution for teeth whitening

Researchers reviewed nanoparticles (NPs) as next-generation whitening agents for teeth.

17 Jun 2022

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Researchers studied the effects of prior immunity on symptomatic infection by SARS-CoV-2 Omicron.

17 Jun 2022

Assessing neurological symptoms present in long COVID patients

Researchers assessed the symptoms of neurological post-acute sequelae of SARS-CoV-2 infection (neuro-PASC) among patients with and without neurologic disorders.

17 Jun 2022

Study explains the structural basis of higher ACE2 binding affinity of Omicron sub-variants

A team of scientists from China has recently deciphered the structural basis of comparatively higher binding affinity of two Omicron sub-variants, namely B.1.1 and B.2, for human angiotensin-converting enzyme 2 (ACE2).

17 Jun 2022

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers reported on the misclassification of the SARS-CoV-2 Omicron BA.1 subvariant as Omicron BA.2 subvariant in an automated variant-specific polymerase chain reaction analysis.

17 Jun 2022

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Researchers assessed the characteristics of the brain fog reported by some COVID-19 patients.

17 Jun 2022

Scientists explore effectiveness of neutralizing antibodies against SARS-CoV-2 Omicron variant

Researchers assessed the impact of SARS-CoV-2-neutralizing antibodies on the SARS-CoV-2 Omicron variant.

17 Jun 2022

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.

17 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

How effective are mRNA COVID-19 vaccine boosters against Omicron?

Long-COVID risk reduced with Omicron versus Delta

Combating monkeypox during COVID-19

Disease ecologist receives $3.5 million to take modeling to the next level with EpiMoRPH

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

Nanoparticles may be the next-generation solution for teeth whitening

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Assessing neurological symptoms present in long COVID patients

Study explains the structural basis of higher ACE2 binding affinity of Omicron sub-variants

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Scientists explore effectiveness of neutralizing antibodies against SARS-CoV-2 Omicron variant

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

GPR183 gene a novel drug target for severe COVID-19

HIV coinfection significantly impacts B cell response to SARS-CoV-2

Novel luminescent biosensor detects SARS-CoV-2 spike protein using cell phone camera

Co-circulation of respiratory viruses during the SARS-CoV-2 Alpha surge

Glucose meter can detect SARS-CoV-2 antibodies in patient samples

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in